Alps Advisors Inc Pacific Biosciences Of California, Inc. Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$19.26 - $30.08 $318,887 - $498,034	-16,557 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $89,620 - $126,247	-3,605 Reduced 17.88%	16,557 $423,000
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $16,100 - $26,006	-722 Reduced 3.46%	20,162 $705,000
Q1 2021 May 07, 2021	SELL	$26.38 - $51.15 $133,113 - $258,102	-5,046 Reduced 19.46%	20,884 $696,000
Q4 2020 Feb 03, 2021	SELL	$10.5 - $28.5 $453,453 - $1.23 Million	-43,186 Reduced 62.48%	25,930 $673,000
Q3 2020 Nov 04, 2020	SELL	$3.61 - $9.87 $146,049 - $399,310	-40,457 Reduced 36.92%	69,116 $682,000
Q2 2020 Aug 05, 2020	BUY	$2.65 - $4.03 $290,368 - $441,579	109,573 New	109,573 $378,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $461M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.